Júlia Starková

1.0k total citations
44 papers, 548 citations indexed

About

Júlia Starková is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Júlia Starková has authored 44 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 24 papers in Public Health, Environmental and Occupational Health and 23 papers in Hematology. Recurrent topics in Júlia Starková's work include Acute Lymphoblastic Leukemia research (24 papers), Acute Myeloid Leukemia Research (18 papers) and Chronic Myeloid Leukemia Treatments (10 papers). Júlia Starková is often cited by papers focused on Acute Lymphoblastic Leukemia research (24 papers), Acute Myeloid Leukemia Research (18 papers) and Chronic Myeloid Leukemia Treatments (10 papers). Júlia Starková collaborates with scholars based in Czechia, United Kingdom and United States. Júlia Starková's co-authors include Jan Trka, Markéta Žaliová, Jan Starý, Ondřej Hrušák, Ivana Heřmanová, Ester Mejstříková, Karel Fišer, Jan Zuna, Jan Stuchlý and Alena Musilová and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Júlia Starková

40 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Júlia Starková Czechia 16 293 234 204 93 90 44 548
Bastien Gerby France 9 231 0.8× 220 0.9× 211 1.0× 71 0.8× 36 0.4× 18 530
Angelo B. A. Laranjeira United States 14 325 1.1× 133 0.6× 171 0.8× 64 0.7× 36 0.4× 35 620
LA Smets Netherlands 7 186 0.6× 185 0.8× 140 0.7× 29 0.3× 51 0.6× 10 360
Victoria Grandage United Kingdom 9 492 1.7× 264 1.1× 472 2.3× 64 0.7× 62 0.7× 16 926
Chandrika Gowda United States 10 189 0.6× 139 0.6× 131 0.6× 19 0.2× 44 0.5× 23 340
Gloria Milani Italy 11 251 0.9× 100 0.4× 95 0.5× 57 0.6× 21 0.2× 16 420
W-D Ludwig Germany 13 397 1.4× 213 0.9× 278 1.4× 79 0.8× 41 0.5× 13 756
Maike Schmitz Germany 5 249 0.8× 81 0.3× 71 0.3× 35 0.4× 16 0.2× 7 400
Fiona C. Brown Australia 13 470 1.6× 74 0.3× 260 1.3× 51 0.5× 29 0.3× 27 697
Ashwini Yenamandra United States 9 363 1.2× 30 0.1× 100 0.5× 65 0.7× 19 0.2× 21 523

Countries citing papers authored by Júlia Starková

Since Specialization
Citations

This map shows the geographic impact of Júlia Starková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Júlia Starková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Júlia Starková more than expected).

Fields of papers citing papers by Júlia Starková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Júlia Starková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Júlia Starková. The network helps show where Júlia Starková may publish in the future.

Co-authorship network of co-authors of Júlia Starková

This figure shows the co-authorship network connecting the top 25 collaborators of Júlia Starková. A scholar is included among the top collaborators of Júlia Starková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Júlia Starková. Júlia Starková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Žaliová, Markéta, et al.. (2024). Rewired glutamate metabolism diminishes cytostatic action of L-asparaginase. Cancer Letters. 605. 217242–217242. 4 indexed citations
2.
Šimčíková, Daniela, Tiziana Pivetta, Michal Hendrych, et al.. (2024). Metabolism of primary high-grade serous ovarian carcinoma (HGSOC) cells under limited glutamine or glucose availability. SHILAP Revista de lepidopterología. 12(1). 27–27.
3.
Starková, Júlia, et al.. (2024). Aspartate in tumor microenvironment and beyond: Metabolic interactions and therapeutic perspectives. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(8). 167451–167451. 5 indexed citations
4.
Heřmanová, Ivana, et al.. (2022). PTEN/PI3K/Akt pathway alters sensitivity of T-cell acute lymphoblastic leukemia to l-asparaginase. Scientific Reports. 12(1). 4043–4043. 14 indexed citations
5.
Starková, Júlia, et al.. (2022). Targeting amino acid metabolism in cancer. International review of cell and molecular biology. 373. 37–79. 27 indexed citations
6.
7.
Pecinová, Alena, David Pajuelo Reguera, Markéta Žaliová, et al.. (2020). Metabolic profile of leukemia cells influences treatment efficacy of L-asparaginase. BMC Cancer. 20(1). 526–526. 19 indexed citations
8.
Žaliová, Markéta, Eliška Potůčková, Alena Musilová, et al.. (2019). ERG deletions in childhood acute lymphoblastic leukemia with DUX4 rearrangements are mostly polyclonal, prognostically relevant and their detection rate strongly depends on screening method sensitivity. Haematologica. 104(7). 1407–1416. 31 indexed citations
9.
Žaliová, Markéta, Jan Stuchlý, Alena Musilová, et al.. (2019). Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort. Haematologica. 104(7). 1396–1406. 71 indexed citations
10.
Potůčková, Eliška, Lucie Šrámková, Jan Starý, et al.. (2018). Two novel fusion genes, AIF1L‐ETV6 and ABL1‐AIF1L, result together with ETV6‐ABL1 from a single chromosomal rearrangement in acute lymphoblastic leukemia with prenatal origin. Genes Chromosomes and Cancer. 57(9). 471–477. 4 indexed citations
11.
Valcárcel-Jiménez, Lorea, Natalia Martín-Martín, Ana R. Cortázar, et al.. (2018). Integrative analysis of transcriptomics and clinical data uncovers the tumor-suppressive activity of MITF in prostate cancer. Cell Death and Disease. 9(10). 1041–1041. 15 indexed citations
12.
Starková, Júlia, et al.. (2018). Assessment of the Metabolic Profile of Primary Leukemia Cells. Journal of Visualized Experiments. 2 indexed citations
13.
Starková, Júlia, et al.. (2017). Altered Metabolism of Leukemic Cells: New Therapeutic Opportunity. International review of cell and molecular biology. 336. 93–147. 8 indexed citations
14.
Heřmanová, Ivana, Amaia Arruabarrena-Aristorena, Karel Vališ, et al.. (2015). Pharmacological inhibition of fatty-acid oxidation synergistically enhances the effect of l-asparaginase in childhood ALL cells. Leukemia. 30(1). 209–218. 38 indexed citations
15.
Heřmanová, Ivana, Markéta Žaliová, Jan Trka, & Júlia Starková. (2012). Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase. Experimental Hematology. 40(8). 657–665. 38 indexed citations
16.
Zápotocký, Michal, Ester Mejstříková, Karel Smetana, et al.. (2012). Valproic acid triggers differentiation and apoptosis in AML1/ETO-positive leukemic cells specifically. Cancer Letters. 319(2). 144–153. 25 indexed citations
17.
Starková, Júlia, et al.. (2010). HOX gene expression in phenotypic and genotypic subgroups and low HOXA gene expression as an adverse prognostic factor in pediatric ALL. Pediatric Blood & Cancer. 55(6). 1072–1082. 24 indexed citations
18.
Smetana, Karel, et al.. (2009). To the nucleolar density and size in apoptotic human leukemic myeloblasts produced in vitro by Trichostatin A. European Journal of Histochemistry. 52(3). 143–143. 6 indexed citations
19.
Smetana, Karel, Michal Zápotocký, Júlia Starková, & Jan Trka. (2007). Effect of histone deacetylase inhibitors on the cell nucleus and nucleolus of leukemic myeloblasts in vitro – A cytochemical study. Acta Histochemica. 109(5). 413–419. 5 indexed citations
20.
Kutschy, Peter, et al.. (2000). Cytotoxic effect of cruciferous phytoalexins against murine L1210 leukemia and B16 melanoma.. 55(6). 701–707. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bastien Gerby Breakdown of academic impact, for papers by Angelo B. A. Laranjeira Breakdown of academic impact, for papers by LA Smets Breakdown of academic impact, for papers by Victoria Grandage Breakdown of academic impact, for papers by Chandrika Gowda Breakdown of academic impact, for papers by Gloria Milani Breakdown of academic impact, for papers by W-D Ludwig Breakdown of academic impact, for papers by Maike Schmitz Breakdown of academic impact, for papers by Fiona C. Brown Breakdown of academic impact, for papers by Ashwini Yenamandra
Rankless by CCL
2026